A Multicenter, Multinational, Open Label Study on the Efficacy and Safety of Infliximab Monotherapy in Moderate-to-Severe Chronic Plaque Psoriasis in Middle Eastern Population.
Phase of Trial: Phase II
Latest Information Update: 15 May 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 10 Mar 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.
- 03 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2008 New trial record.